Cumberland Pharmaceuticals (CPIX) Long-Term Debt Repayments (2017 - 2025)
Historic Long-Term Debt Repayments for Cumberland Pharmaceuticals (CPIX) over the last 12 years, with Q1 2025 value amounting to $10.0 million.
- Cumberland Pharmaceuticals' Long-Term Debt Repayments rose 3033.04% to $10.0 million in Q1 2025 from the same period last year, while for Sep 2025 it was $16.4 million, marking a year-over-year decrease of 5642.15%. This contributed to the annual value of $36.0 million for FY2024, which is 317.0% up from last year.
- Cumberland Pharmaceuticals' Long-Term Debt Repayments amounted to $10.0 million in Q1 2025, which was up 3033.04% from $6.3 million recorded in Q4 2024.
- In the past 5 years, Cumberland Pharmaceuticals' Long-Term Debt Repayments registered a high of $20.0 million during Q2 2022, and its lowest value of $6.3 million during Q4 2024.
- For the 5-year period, Cumberland Pharmaceuticals' Long-Term Debt Repayments averaged around $11.3 million, with its median value being $10.9 million (2023).
- Its Long-Term Debt Repayments has fluctuated over the past 5 years, first soared by 7647.06% in 2021, then tumbled by 4581.52% in 2023.
- Cumberland Pharmaceuticals' Long-Term Debt Repayments (Quarter) stood at $14.0 million in 2021, then tumbled by 45.0% to $7.7 million in 2022, then grew by 1.8% to $7.8 million in 2023, then fell by 19.44% to $6.3 million in 2024, then skyrocketed by 58.9% to $10.0 million in 2025.
- Its Long-Term Debt Repayments stands at $10.0 million for Q1 2025, versus $6.3 million for Q4 2024 and $11.0 million for Q3 2024.